Skip to main content

The Globe and Mail

Canopy Growth signs deal to supply Australian company with medical cannabis

It is the second international deal announced by Canopy this week.

Hand-out/Canopy Growth Corporation

Canopy Growth Corp. has signed an agreement with AusCann Group Holdings Ltd. to be its exclusive supplier of medical cannabis for the Australian market.

Canada's largest licensed cannabis producer says it will start with the transfer of a range of medicines for research and commercialization in Australia.

The deal allows Canopy to pursue other Australian opportunities.

Story continues below advertisement

The agreement follows a partnership deal last year that saw Canopy take stake in AusCann in exchange for expertise in a number of areas including production, quality assurance and operations.

It is the second international deal announced by Canopy this week.

On Monday, Canopy signed a deal to provide certain marijuana strains and seeds to Spanish pharmaceutical producer Alcaliber.

Andrew Willis: Why you shouldn't buy into the pot boom and bust (The Globe and Mail)
Report an error
Comments

The Globe invites you to share your views. Please stay on topic and be respectful to everyone. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

We’ve made some technical updates to our commenting software. If you are experiencing any issues posting comments, simply log out and log back in.

Discussion loading… ✨

Combined Shape Created with Sketch.

Combined Shape Created with Sketch.

Thank you!

You are now subscribed to the newsletter at

You can unsubscribe from this newsletter or Globe promotions at any time by clicking the link at the bottom of the newsletter, or by emailing us at privacy@globeandmail.com.